✦ LIBER ✦

Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function

✍ Scribed by D.G Farmer; S.V McDiarmid; S Edelstein; J.F Renz; G Hisatake; G Cortina; C Fondevila; M Correa; S Rhodes; A Zafar; Y Chavez; H Yersiz; R.W Busuttil

Book ID: 116929658
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 49 KB
Volume: 36
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2004.01.099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IL2-receptor antagonist (basiliximab) in

IL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipients

✍ B.Y. Choy; T.M. Chan; F.K. Li; S.L. Lui; W.K. Lo; T. Yip; K.C. Tse; K.N. Lai 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Late Acute Humoral Rejection in Low-Risk

Late Acute Humoral Rejection in Low-Risk Renal Transplant Recipients Induced With an Interleukin-2 Receptor Antagonist and Maintained With Standard Therapy: Preliminary Communication

✍ J. Morales; L. Contreras; C. Zehnder; V. Pinto; M. Elberg; S. Araneda; C. Herzog 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 128 KB